TY - JOUR A1 - Üçeyler, Nurcan A1 - Schäfer, Kristina A. A1 - Mackenrodt, Daniel A1 - Sommer, Claudia A1 - Müllges, Wolfgang T1 - High-Resolution Ultrasonography of the Superficial Peroneal Motor and Sural Sensory Nerves May Be a Non-invasive Approach to the Diagnosis of Vasculitic Neuropathy JF - Frontiers in Neurology N2 - High-resolution ultrasonography (HRUS) is an emerging new tool in the investigation of peripheral nerves. We set out to assess the utility of HRUS performed at lower extremity nerves in peripheral neuropathies. Nerves of 26 patients with polyneuropathies of different etiologies and 26 controls were investigated using HRUS. Patients underwent clinical, laboratory, electrophysiological assessment, and a diagnostic sural nerve biopsy as part of the routine work-up. HRUS was performed at the sural, tibial, and the common, superficial, and deep peroneal nerves. The superficial peroneal nerve longitudinal diameter (LD) distinguished best between the groups: patients with immune-mediated neuropathies (n = 13, including six with histology-proven vasculitic neuropathy) had larger LD compared to patients with non-immune-mediated neuropathies (p < 0.05) and to controls (p < 0.001). Among all subgroups, patients with vasculitic neuropathy showed the largest superficial peroneal nerve LD (p < 0.001) and had a larger sural nerve cross-sectional area when compared with disease controls (p < 0.001). Enlargement of the superficial peroneal and sural nerves as detected by HRUS may be a useful additional finding in the differential diagnosis of vasculitic and other immune-mediated neuropathies. KW - peripheral neuropathy KW - nerve ultrasonography KW - vasculitis KW - sural nerve KW - superficial peroneal nerve Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-146671 VL - 7 IS - 48 ER - TY - JOUR A1 - Yadav, Preeti A1 - Selvaraj, Bhuvaneish T. A1 - Bender, Florian L. P. A1 - Behringer, Marcus A1 - Moradi, Mehri A1 - Sivadasan, Rajeeve A1 - Dombert, Benjamin A1 - Blum, Robert A1 - Asan, Esther A1 - Sauer, Markus A1 - Julien, Jean-Pierre A1 - Sendtner, Michael T1 - Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling JF - Acta Neuropathologica N2 - In neurons, microtubules form a dense array within axons, and the stability and function of this microtubule network is modulated by neurofilaments. Accumulation of neurofilaments has been observed in several forms of neurodegenerative diseases, but the mechanisms how elevated neurofilament levels destabilize axons are unknown so far. Here, we show that increased neurofilament expression in motor nerves of pmn mutant mice, a model of motoneuron disease, causes disturbed microtubule dynamics. The disease is caused by a point mutation in the tubulin-specific chaperone E (Tbce) gene, leading to an exchange of the most C-terminal amino acid tryptophan to glycine. As a consequence, the TBCE protein becomes instable which then results in destabilization of axonal microtubules and defects in axonal transport, in particular in motoneurons. Depletion of neurofilament increases the number and regrowth of microtubules in pmn mutant motoneurons and restores axon elongation. This effect is mediated by interaction of neurofilament with the stathmin complex. Accumulating neurofilaments associate with stathmin in axons of pmn mutant motoneurons. Depletion of neurofilament by Nefl knockout increases Stat3-stathmin interaction and stabilizes the microtubules in pmn mutant motoneurons. Consequently, counteracting enhanced neurofilament expression improves axonal maintenance and prolongs survival of pmn mutant mice. We propose that this mechanism could also be relevant for other neurodegenerative diseases in which neurofilament accumulation and loss of microtubules are prominent features. KW - Amyotrophic-lateral-sclerosis KW - Transgenic mice KW - Mouse model KW - Alzheimers disease KW - Neurofilament KW - Progressive motor neuronopathy KW - Axonal transport KW - Intermediate filaments KW - Motoneuron disease KW - Lacking neurofilaments KW - Missense mutation KW - Axon degeneration KW - Microtubules KW - Stathmin KW - Stat3 Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-188234 VL - 132 IS - 1 ER - TY - JOUR A1 - Wiessler, Anna-Lena A1 - Talucci, Ivan A1 - Piro, Inken A1 - Seefried, Sabine A1 - Hörlin, Verena A1 - Baykan, Betül B. A1 - Tüzün, Erdem A1 - Schaefer, Natascha A1 - Maric, Hans M. A1 - Sommer, Claudia A1 - Villmann, Carmen T1 - Glycine receptor β–targeting autoantibodies contribute to the pathology of autoimmune diseases JF - Neurology: Neuroimmunology & Neuroinflammation N2 - Background and Objectives Stiff-person syndrome (SPS) and progressive encephalomyelitis with rigidity and myoclonus (PERM) are rare neurologic disorders of the CNS. Until now, exclusive GlyRα subunit–binding autoantibodies with subsequent changes in function and surface numbers were reported. GlyR autoantibodies have also been described in patients with focal epilepsy. Autoimmune reactivity against the GlyRβ subunits has not yet been shown. Autoantibodies against GlyRα1 target the large extracellular N-terminal domain. This domain shares a high degree of sequence homology with GlyRβ making it not unlikely that GlyRβ-specific autoantibody (aAb) exist and contribute to the disease pathology. Methods In this study, we investigated serum samples from 58 patients for aAb specifically detecting GlyRβ. Studies in microarray format, cell-based assays, and primary spinal cord neurons and spinal cord tissue immunohistochemistry were performed to determine specific GlyRβ binding and define aAb binding to distinct protein regions. Preadsorption approaches of aAbs using living cells and the purified extracellular receptor domain were further used. Finally, functional consequences for inhibitory neurotransmission upon GlyRβ aAb binding were resolved by whole-cell patch-clamp recordings. Results Among 58 samples investigated, cell-based assays, tissue analysis, and preadsorption approaches revealed 2 patients with high specificity for GlyRβ aAb. Quantitative protein cluster analysis demonstrated aAb binding to synaptic GlyRβ colocalized with the scaffold protein gephyrin independent of the presence of GlyRα1. At the functional level, binding of GlyRβ aAb from both patients to its target impair glycine efficacy. Discussion Our study establishes GlyRβ as novel target of aAb in patients with SPS/PERM. In contrast to exclusively GlyRα1-positive sera, which alter glycine potency, aAbs against GlyRβ impair receptor efficacy for the neurotransmitter glycine. Imaging and functional analyses showed that GlyRβ aAbs antagonize inhibitory neurotransmission by affecting receptor function rather than localization. KW - autoantibody (aAb) KW - glycine receptor (GlyR) KW - stiff-person syndrome (SPS) KW - clinical neurology KW - movement disorders KW - progressive encephalitis with rigidity and myoclonus (PERM) Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-349958 VL - 11 IS - 2 ER - TY - JOUR A1 - Wieland, Annalena A1 - Strissel, Pamela L. A1 - Schorle, Hannah A1 - Bakirci, Ezgi A1 - Janzen, Dieter A1 - Beckmann, Matthias W. A1 - Eckstein, Markus A1 - Dalton, Paul D. A1 - Strick, Reiner T1 - Brain and breast cancer cells with PTEN loss of function reveal enhanced durotaxis and RHOB dependent amoeboid migration utilizing 3D scaffolds and aligned microfiber tracts JF - Cancers N2 - Background: Glioblastoma multiforme (GBM) and metastatic triple-negative breast cancer (TNBC) with PTEN mutations often lead to brain dissemination with poor patient outcome, thus new therapeutic targets are needed. To understand signaling, controlling the dynamics and mechanics of brain tumor cell migration, we implemented GBM and TNBC cell lines and designed 3D aligned microfibers and scaffolds mimicking brain structures. Methods: 3D microfibers and scaffolds were printed using melt electrowriting. GBM and TNBC cell lines with opposing PTEN genotypes were analyzed with RHO-ROCK-PTEN inhibitors and PTEN rescue using live-cell imaging. RNA-sequencing and qPCR of tumor cells in 3D with microfibers were performed, while scanning electron microscopy and confocal microscopy addressed cell morphology. Results: In contrast to the PTEN wildtype, GBM and TNBC cells with PTEN loss of function yielded enhanced durotaxis, topotaxis, adhesion, amoeboid migration on 3D microfibers and significant high RHOB expression. Functional studies concerning RHOB-ROCK-PTEN signaling confirmed the essential role for the above cellular processes. Conclusions: This study demonstrates a significant role of the PTEN genotype and RHOB expression for durotaxis, adhesion and migration dependent on 3D. GBM and TNBC cells with PTEN loss of function have an affinity for stiff brain structures promoting metastasis. 3D microfibers represent an important tool to model brain metastasizing tumor cells, where RHO-inhibitors could play an essential role for improved therapy. KW - 3D tumor model KW - 3D microfiber KW - amoeboid cell migration KW - brain cancer KW - breast cancer KW - PTEN KW - RHO KW - ROCK KW - durotaxis KW - topotaxis Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-248443 SN - 2072-6694 VL - 13 IS - 20 ER - TY - JOUR A1 - Wetzel, Andrea A1 - Jablonka, Sibylle A1 - Blum, Robert T1 - Cell-autonomous axon growth of young motoneurons is triggered by a voltage-gated sodium channel JF - Channels (Austin) N2 - Spontaneous electrical activity preceding synapse formation contributes to the precise regulation of neuronal development. Examining the origins of spontaneous activity revealed roles for neurotransmitters that depolarize neurons and activate ion channels. Recently, we identified a new molecular mechanism underlying fluctuations in spontaneous neuronal excitability. We found that embryonic motoneurons with a genetic loss of the low-threshold sodium channel Na\(_V\)1.9 show fewer fluctuations in intracellular calcium in axonal compartments and growth cones than wild-type littermates. As a consequence, axon growth of Na\(_V\)1.9-deficient motoneurons in cell culture is drastically reduced while dendritic growth and cell survival are not affected. Interestingly, Na\(_V\)1.9 function is observed under conditions that would hardly allow a ligand- or neurotransmitter-dependent depolarization. Thus, Na\(_V\)1.9 may serve as a cell-autonomous trigger for neuronal excitation. In this addendum, we discuss a model for the interplay between cell-autonomous local neuronal activity and local cytoskeleton dynamics in growth cone function. KW - spontaneous excitation KW - spinal muscular atrophy KW - axon growth KW - sodium channel KW - motoneurons KW - local protein synthesis KW - NaV1.9 Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-132586 VL - 7 IS - 1 ER - TY - THES A1 - von Wardenburg, Niels Oliver T1 - Investigations into the Pathogenic Antibody-Antigen-Interference of Glycine Receptor Autoantibodies T1 - Untersuchungen zur pathogenen Antikörper-Antigen-Interferenz von Autoantikörpern gegen den Glycinrezeptor N2 - Anti-glycine receptor (GlyR) autoantibodies belong to the novel group of autoantibodies that target neuronal cell-surface antigens (NCS), which are accompanied with various neurologic and neuropsychiatric conditions. The inhibitory ionotropic GlyR is one of the major inhibitory neurotransmitter receptors and therefore involved in maintaining homeostasis of neuronal excitation levels at brain stem and spinal cord. Anti-GlyR autoantibodies are associated with progressive encephalomyelitis with rigidity and myoclonus or stiff person syndrome. These neuromotor disorders are characterized by exaggerated startle, muscle stiffness, and painful spasms, leading to immobility and fatal outcome in some cases. It was hypothesized that imbalance of motoneuronal inhibition by functional impairment of GlyR and receptor internalization are direct consequences of antibody-antigen interference. Here, serum samples of four patients were tested for anti-GlyR autoantibodies and were used for the analysis of the functional impact on the electrophysiological properties of recombinant GlyRs, transiently expressed in HEK293 cells. Furthermore, the recognition pattern of anti- GlyR autoantibodies to human, zebrafish and chimeric GlyRα1 located the epitope to the far N-terminal region. The pathogenicity of anti-GlyR autoantibodies and thereby the autoimmunologic etiology of the disease was confirmed by passive transfer of patient serum to zebrafish (Danio rerio) larvae, that yielded an abnormal escape response – a brain stem reflex that corresponds to the exaggerated startle of afflicted patients. The phenotype was accompanied by profound reduction of GlyR clusters in spinal cord cryosections of treated zebrafish larvae. Together, these novel insights into the pathogenicity of GlyR autoantibodies confirm the concept of a novel neurologic autoimmune disease and might contribute to the development of innovative therapeutic strategies. N2 - GlyR Autoantikörper sind mit dem Stiff-Person-Syndrom assoziiert, insbesondere mit der schwerverlaufenden Variante der Progressiven Enzephalopathie mit Rigidität und Myoklonus. Diese Studie hat sich als Ziel gesetzt, die Pathogenität der Autoantikörper sowie deren pathogenen Eigenschaften mit Hilfe der Patch-Clamp-Methode sowie eines passiven Transfers der Erkrankung auf Zebrafischlarven zu erklären. ... KW - stiff person syndrome KW - glycine receptor autoantibodies Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-247217 ER - TY - JOUR A1 - von Collenberg, Cora R. A1 - Schmitt, Dominique A1 - Rülicke, Thomas A1 - Sendtner, Michael A1 - Blum, Robert A1 - Buchner, Erich T1 - An essential role of the mouse synapse-associated protein Syap1 in circuits for spontaneous motor activity and rotarod balance JF - Biology Open N2 - Synapse-associated protein 1 (Syap1) is the mammalian homologue of synapse-associated protein of 47 kDa (Sap47) in Drosophila. Genetic deletion of Sap47 leads to deficiencies in short-term plasticity and associative memory processing in flies. In mice, Syap1 is prominently expressed in the nervous system, but its function is still unclear. We have generated Syap1 knockout mice and tested motor behaviour and memory. These mice are viable and fertile but display distinct deficiencies in motor behaviour. Locomotor activity specifically appears to be reduced in early phases when voluntary movement is initiated. On the rotarod, a more demanding motor test involving control by sensory feedback, Syap1-deficient mice dramatically fail to adapt to accelerated speed or to a change in rotation direction. Syap1 is highly expressed in cerebellar Purkinje cells and cerebellar nuclei. Thus, this distinct motor phenotype could be due to a so-far unknown function of Syap1 in cerebellar sensorimotor control. The observed motor defects are highly specific since other tests in the modified SHIRPA exam, as well as cognitive tasks like novel object recognition, Pavlovian fear conditioning, anxiety-like behaviour in open field dark-light transition and elevated plus maze do not appear to be affected in Syap1 knockout mice. KW - Syap1 knockout KW - Motor behaviour KW - Associative learning KW - Fear conditioning KW - Object recognition Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-201986 N1 - PDF includes: Correction: An essential role of the mouse synapse-associated protein Syap1 in circuits for spontaneous motor activity and rotarod balance - February 15, 2020. Biology Open (2020) 9, bio048942. doi:10.1242/bio.048942 VL - 8 ER - TY - JOUR A1 - Vollmuth, Christoph A1 - Muljukov, Olga A1 - Abu-Mugheisib, Mazen A1 - Angermeier, Anselm A1 - Barlinn, Jessica A1 - Busetto, Loraine A1 - Grau, Armin J. A1 - Günther, Albrecht A1 - Gumbinger, Christoph A1 - Hubert, Nikolai A1 - Hüttemann, Katrin A1 - Klingner, Carsten A1 - Naumann, Markus A1 - Palm, Frederick A1 - Remi, Jan A1 - Rücker, Viktoria A1 - Schessl, Joachim A1 - Schlachetzki, Felix A1 - Schuppner, Ramona A1 - Schwab, Stefan A1 - Schwartz, Andreas A1 - Trommer, Adrian A1 - Urbanek, Christian A1 - Volbers, Bastian A1 - Weber, Joachim A1 - Wojciechowski, Claudia A1 - Worthmann, Hans A1 - Zickler, Philipp A1 - Heuschmann, Peter U. A1 - Haeusler, Karl Georg A1 - Hubert, Gordian Jan T1 - Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020 JF - European Journal of Neurology N2 - Background and purpose The effects of the coronavirus disease 2019 (COVID-19) pandemic on telemedical care have not been described on a national level. Thus, we investigated the medical stroke treatment situation before, during, and after the first lockdown in Germany. Methods In this nationwide, multicenter study, data from 14 telemedical networks including 31 network centers and 155 spoke hospitals covering large parts of Germany were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke treatment. A survey focusing on potential shortcomings of in-hospital and (telemedical) stroke care during the pandemic was conducted. Results Between January 2018 and June 2020, 67,033 telemedical consultations and 38,895 telemedical stroke consultations were conducted. A significant decline of telemedical (p < 0.001) and telemedical stroke consultations (p < 0.001) during the lockdown in March/April 2020 and a reciprocal increase after relaxation of COVID-19 measures in May/June 2020 were observed. Compared to 2018–2019, neither stroke patients' age (p = 0.38), gender (p = 0.44), nor severity of ischemic stroke (p = 0.32) differed in March/April 2020. Whereas the proportion of ischemic stroke patients for whom endovascular treatment (14.3% vs. 14.6%; p = 0.85) was recommended remained stable, there was a nonsignificant trend toward a lower proportion of recommendation of intravenous thrombolysis during the lockdown (19.0% vs. 22.1%; p = 0.052). Despite the majority of participating network centers treating patients with COVID-19, there were no relevant shortcomings reported regarding in-hospital stroke treatment or telemedical stroke care. Conclusions Telemedical stroke care in Germany was able to provide full service despite the COVID-19 pandemic, but telemedical consultations declined abruptly during the lockdown period and normalized after relaxation of COVID-19 measures in Germany. KW - COVID-19 KW - SARS-CoV- 2 KW - stroke KW - telemedicine KW - survey Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259396 VL - 28 IS - 10 ER - TY - THES A1 - Tranziska, Ann-Kathrin T1 - Untersuchungen zum molekularen Pathomechanismus der SMA durch Anaylse der Smn-Interaktionspartner hnRNP-R und hnRNP-Q T1 - Research on the pathomechanism of SMA by analysing the Smn interaction partners hnRNP-R and hnRNP-Q N2 - Spinale Muskelatrophie (SMA), die häufigste autosomal rezessive neuromuskuläre Erkrankung bei Kindern und jungen Erwachsenen, wird durch Mutationen in der telomeren Kopie des survival motor neuron (SMN1) Gens auf dem humanen Chromosom 5 verursacht. Anders als bei Mäusen, welche nur ein Smn Gen haben, gibt es beim Menschen eine zweite Kopie (SMN2). Das Genprodukt dieser zweiten Kopie wird am C-Terminus bevorzugt alternativ gespleißt. Es bringt nur eine kleine Menge des vollständigen SMN Proteins hervor. Der Grund, warum eine reduzierte Menge des ubiquitär exprimierten SMN Proteins speziell zu einer Motorneuronendegeneration führt, ohne andere Zelltypen gleichermaßen zu betreffen ist noch immer nicht bekannt. Mit Hilfe der Yeast-Two-Hybrid Technik wurden die beiden heterogenen nukleären Ribonukleoproteine hnRNP-R und hnRNP-Q als neue SMN-bindende Proteine identifiziert. Diese beiden hochhomologen Proteine waren bereits bekannt und stehen in Verbindung mit dem RNA Metabolismus, im Speziellen: Editing, Transport und Spleißing. hnRNP-R und -Q interagieren mit Wildtyp Smn, aber nicht mit trunkierten oder mutierten Smn Formen, welche in SMA-Patienten gefunden wurden. Beide Proteine werden in den meisten Geweben exprimiert. Im Rückenmark von Mäusen ist die stärkste Expression am neunzehnten embryonalen Tag zu beobachten. Interessanterweise ist hnRNP-R hauptsächlich in den Axonen von Motoneuronen zu finden und kolokalisiert dort mit Smn. Im Mausmodell für die SMA konnte gezeigt werden, dass sich die Motoneurone von erkrankten Mäusen hinsichtlich der Morphologie ihrer Neuriten von solchen aus Wildtyp Mäusen unterscheiden. Werden hnRNP-R oder hnRNP-Q in kultivierten Nervenzellen exprimiert, so fördern sie das Wachstum von Neuriten. Bei SMA-Patienten ohne Mutation im SMN Gen konnte allerdings weder Mutation noch Deletion in hnRNP-R oder hnRNP-Q nachgewiesen werden. Die Ergebnisse dieser Arbeit können entscheidend zu einem besseren Verständnis der motoneuronen spezifischen Funktion von Smn bei der SMA beitragen. N2 - Spinal muscular atrophy (SMA), the most common hereditary motor neuron disease in children and young adults is caused by mutations in or loss of the telomeric survival motor neuron (SMN1) gene on human chromosome 5. The human genome, in contrast to mouse, contains a second SMN gene (SMN2) which is transcribed into an mRNA, that is predominantly alternatively spliced at the C-terminus. Therefore, it gives rise to low levels of full-length SMN protein. The reason why reduced levels of the ubiquitously expressed SMN protein lead to specific motor neuron degeneration without affecting other cell types is still not understood. Using yeast two-hybrid techniques, hnRNP-R and the highly related hnRNP-Q were identified as novel SMN interaction partners. These highly homologous proteins were known before in the context of RNA metabolism, in particular: editing, transport and splicing. HnRNP-R and -Q interact with wildtype Smn but not with truncated or mutant Smn forms identified in SMA patients. Both proteins are expressed in most tissues. In the mouse spinal cord the expression peaks at embryonic day nineteen. Interestingly, hnRNP-R is predominantly located in axons of motor neurons where it co-localises with Smn. It could be shown in mouse models for SMA that motor neurons of affected mice differ from wildtype mice in the morphology of their neurites. When hnRNP-R or hnRNP-Q were expressed in neuronal cells they promote neurite outgrowth. However, no mutation or deletion could be found in the genes for hnRNP-R or hnRNP-Q of SMA patients without mutations in the SMN gene. The results of this thesis could help to understand the specific Smn function in motoneurons. KW - Spinale Muskelathropie KW - Genexpression KW - SMA KW - Smn KW - hnRNP-R KW - hnRNP-Q KW - SMA KW - Smn KW - hnRNP-R KW - hnRNP-Q Y1 - 2004 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-8256 ER - TY - THES A1 - Tian, Rui T1 - Structural and functional organization of synaptic proteins in Drosophila melanogaster T1 - Strukturelle und funktionelle Organisation von synaptischen Proteinen in Drosophila melanogaster N2 - Structural and functional modifications of synaptic connections (“synaptic plasticity”) are believed to mediate learning and memory processes. Thus, molecular mechanisms of how synapses assemble in both structural and functional terms are relevant for our understanding of neuronal development as well as the processes of learning and memory. Synapses form by an asymmetric association of highly specialized membrane domains: at the presynaptic active zone transmitter filled vesicles fuse, while transmitter receptors at the opposite postsynaptic density sense this signal. By genetic analysis, matrix proteins of active zones from various families have been shown to be important for fast vesicle fusion, and were suggested to contribute to synapse stability and assembly. The Sigrist lab in collaboration with the Buchner lab previously had shown that the large scaffold protein Bruchpilot (Brp) is essential for both the structural and functional integrity of active zones and for synaptic plasticity in Drosophila melanogaster. The work described in this thesis investigated several candidate proteins which appear to be involved in preand postsynaptic function, as summarized in the following: (1) DREP-2 (DEF45 related protein-2) had been found by co-immunoprecipitations with anti-Brp antibodies by Dr. Manuela Schmidt (unpublished data). Mutants and antibodies for the further study of DREP- 2 were generated in this thesis. Yeast two hybrid results suggest that DREP-2 might interact with dynein light chain 2, while in vivo imaging indicates that DREP-2 might be involved in bidirectional axonal transport. (2) Coimmunoprecipitation and pull down experiments suggested that the ARFGAP [ADP-ribosylation factor (ARF)-directed GTPase activating protein (GAP)] protein GIT (G-protein coupled receptor kinase interacting protein) could interact with the endocytosis associated molecule Stoned B (StnB). Mutants in the dgit gene showed an accumulation of large size vesicles, membrane intermediates and decreased vesicle density at the 3rd instar larval neuromuscular junction (NMJ) by electron microscopy (EM). The phenotypes accumulation of large size vesicles and membrane intermediates could be rescued partially by expression of Drosophila GIT (DGIT) or human GIT in dgit mutant background. Furthermore, by immunofluorescence the dgit mutant shows specifically decreased levels of StnB, which could be restored partially by the expression of DGIT. These results strongly support the suggestion that DGIT interacts with StnB, which is involved in the regulation of vesicle size, endocytosis or recycling of synaptic vesicles (SVs). Furthermore, the dgit mutants also showed signs of a mislocalization of the presynaptic protein Brp relative to the postsynaptic protein GluRIID, which could be rescued by expression of DGIT or human GIT in the dgit mutant background, but not by StnB. These results suggest that GIT on one hand executes roles in the regulation of synaptic vesicle endocytosis, but potentially also has structural roles for synapse assembly (3) Djm-1 is a candidate locus to mediate mental retardation in human patients when it is mutated. As a first step towards an understanding of the mechanistic role of DJM-1, Drosophila genetics were used to address DJM-1 function. So far, however, the djm-1 mutant generated in this thesis did not show a nervous system phenotype. N2 - Es wird angenommen, dass strukturelle und funktionale Änderungen an synaptischen Verbindungen („synaptische Plastizität”) die Grundlage für Lern- und Gedächtnisprozesse darstellen. Daher sind die molekularen Mechanismen des strukturellen und funktionalen Aufbaus von Synapsen wichtig für das Verständnis von neuronaler Entwicklung sowie von Lernund Gedächtnisprozessen. Synapsen werden durch eine asymmetrische Verbindung von zwei hochspezialisierten Membranen gebildet: An der präsynaptischen aktiven Zone fusionieren mit Transmittern gefüllte Vesikel, während Transmitterrezeptoren in der gegenüberliegenden postsynaptischen Dichte dieses Signal wahrnehmen. Durch genetische Analysen wurde gezeigt, dass Matrixproteine der aktiven Zone verschiedener Familien wichtig für die schnelle Vesikelfusion sind. Es wird angenommen, dass diese Proteine zu synaptischer Stabilität und dem Aufbau von Synapsen beitragen. Das Labor von Stephan Sigrist hat in einer Kollaboration mit dem Labor von Erich Buchner in der Vergangenheit gezeigt, dass das große Gerüstprotein Bruchpilot (Brp) essentiell für sowohl die strukturelle und funktionale Intaktheit von aktiven Zonen als auch für synaptische Plastizität in Drosophila melanogaster ist. Im Zuge dieser Doktorarbeit wurden mehrere Kandidatenproteine untersucht, die vermutlich eine Rolle in prä- und postsynaptischer Funktionen spielen, was folgendermaßen zusammengefasst werden kann: 1. DREP-2 (DFF45 related protein 2) wurde von Dr. Manuela Schmidt durch Koimmunpräzipitationen mit Anti-Brp Antikörpern gefunden (unveröffentlichte Daten). Mutanten und Antikörper für die weitere Untersuchung von DREP-2 wurden im Zuge dieser Doktorarbeit erzeugt. Die Ergebnisse aus Hefe-Zwei-Hybrid Versuchen legen nahe, dass DREP- 2 mit Dynein light chain 2 interagieren könnte, während in vivo Bildgebung darauf hindeutet, dass DREP-2 in bidirektionalen axonalen Transport involviert sein könnte. 2. Koimmunpräzipitations- und Pulldown-Experimente ließen den Schluss zu, dass das ARFGAP-Protein (ADP-ribosylation factor (ARF)-directed GTPase activating proteins (GAPs)) GIT (G-protein coupled receptor kinase interacting protein) mit dem mit Endozytose assoziierten Protein Stoned B (StnB) interagieren könnte. Elektronenmikroskopie der neuromuskulären Synapse von Larven im dritten Larvalstadium, die mutant für das dgit-Gen sind, zeigte eine Akkumulation von großen Vesikeln und Membran-Zwischenprodukten sowie eine verringerte Vesikeldichte. Zwei der Phänotypen, die Akkumulation großer Vesikel und der Membran-Zwischenprodukte, konnten durch die Expression von Drosophila GIT (DGIT) oder menschlichem GIT im dgit-mutanten Hintergrund teilweise ausgeglichen werden. Darüberhinaus wurde über Immunofluoreszenz deutlich, dass die dgit-Mutante eine spezifisch reduzierte Menge an StnB enthält, was durch die Expression von DGIT teilweise ausgeglichen werden konnte. Diese Ergebnisse unterstützen die Vorstellung sehr, dass DGIT mit StnB interagiert.. StnB spielt eine Rolle bei der Regulierung von Vesikelgrößen, Endozytose und der Wiederverwertung von synaptischen Vesikeln. Darüberhinaus zeigen dgit Mutanten Hinweise auf eine fehlerhafte Lokalisierung des präsynaptischen Proteins Brp relativ zu dem postsynaptischen Protein GluRIID, was furch die Expression von DGIT oder menschlichem GIT im dgit-mutanten Hintergrund ausgeglichen werden konnte, nicht jedoch durch StnB. Diese Ergebnisse legen den Schluss nahe, dass GIT einerseits eine Rolle bei der Regulierung der Endozytose synaptischer Vesikel spielt aber möglicherweise auch eine strukturelle Funktion beim Aufbau von Synapsen hat. 3. Djm-1 ist ein genetischer Lokus, der geistige Behinderung bei menschlichen Patienten hervorruft, wenn er mutiert vorliegt. Als ersten Schritt in Richtung eines Verständnisses der mechanistischen Rolle von DJM-1, wurde Genetik in Drosophila durchgeführt, um die Funktion von DJM-1 zu untersuchen. Die in dieser Doktorarbeit erzeugte djm-1 Mutante zeigte jedoch bisher keinen anomalen Phänotyp im Nervensystem. KW - Taufliege KW - Synaptische Transmission KW - Proteine KW - synaptisches Protein KW - Drosophila melanogaster KW - Drosophila melanogaster KW - synaptic proteins Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-57399 ER - TY - JOUR A1 - Thoenen, Hans A1 - Hughes, Richard A. A1 - Sendtner, Michael T1 - Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications. N2 - No abstract available Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31746 ER - TY - CHAP A1 - Thoenen, Hans A1 - Hughes, Richard A. A1 - Sendtner, Michael T1 - Towards a comprehensive understanding of the trophic support of motoneurons N2 - Motoneurons played an essential role in establishing the concept of target-mediated support of innervating neurons. However, it took several decades until molecules were identined which trophically support motoneurons in vitro and in vivo. The most potent molecule identined so far is ciliary neurotrophic factor (CNTF). It is expressed as a cytosolic molecule in myelinating Schwann cells rather than in skeletal muscle in the postnatal period and therefore does not qualify as a target-derived neurotrophic factor regulating motoneuron survival during embryonic development. However, the inactivation of CNTF by gene targeting experiments results in progressive atrophy and degeneration of motoneurons, demonstrating that CNTF plays an essential role as a maintenance factor for motoneurons postnatally. Secretory molecules which are expressed in skeletal muscle during embryonic development and which support motoneurons in culture and partially also in vivo include members of the NGF gene family (BDNF, NT-3, NT-4/S) , FGF-S, IGF-I, and UF. The evaluation of the physiological importance of these molecules is under investigation. KW - neurotrophic molecules KW - CNTF KW - gene targeting KW - NGF gene family KW - FGF-5 KW - lIF KW - IGF-I Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31117 ER - TY - THES A1 - Thangaraj Selvaraj, Bhuvaneish T1 - Role of CNTF-STAT3 signaling for microtubule dynamics inaxon growth and maintenance: Implications in motoneuron diseases T1 - Die Funktion des CNTF-STAT3 Signalweges für die Microtubuli Dynamik in Axonalem Wachstum und Axon Erhalt: Implikationen für Motoneuronenerkrankungen N2 - Neurotrophic factor signaling modulates differentiation, axon growth and maintenance, synaptic plasticity and regeneration of neurons after injury. Ciliary neurotrophic factor (CNTF), a Schwann cell derived neurotrophic factor, has an exclusive role in axon maintenance, sprouting and synaptic preservation. CNTF, but not GDNF, has been shown to alleviate motoneuron degeneration in pmn mutant mice carrying a missense mutation in Tbce gene, a model for Amyotrophic Lateral Sclerosis (ALS). This current study elucidates the distinct signaling mechanism by which CNTF rescues the axonal degeneration in pmn mutant mice. ... N2 - Neurotrophe Faktoren beeinflussendie die neuronale Differenzierung, das Wachstum und die Stabilisierung von Axonen sowie Synaptische Plastizität und die Regeneration von Neuronen nach Verletzung. Der von Schwannzellen synthetisierte neurotrophe Faktor Ciliary neurotrophic factor (CNTF) spielt eine wichtige Rolle bei der axonalen Erhaltung sowie bei der Induktion und Reduktion von axonalen Verzweigungen. Die Behandlung der pmn Mausmutante mit CNTF, aber nicht mit GDNF führt zu einem späteren Krankheitsbeginn und verminderten Fortschreiten der Motoneuronendegeneration. Diese Mausmutante, die eine Punktmutation im Tbce Gen trägt, dient als Modell für die Amyotrophe Lateralsklerose. Ziel der vorliegenden Arbeit war es, die zugrunde liegenden Signalkaskaden aufzudecken, die den CNTF-vermittelten Effekt auf den Krnakheitsverlauf bei der pmn Maus verursachen. ... KW - Ciliary neurotrophic factor KW - STAT KW - CNTF KW - STAT3 KW - Stathmin KW - Microtubules KW - Signaltransduktion KW - Motoneuron KW - Krankheit Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-76889 ER - TY - JOUR A1 - Tejero, Rocio A1 - Alsakkal, Mohammad A1 - Hennlein, Luisa A1 - Lopez-Cabello, Ana M. A1 - Jablonka, Sibylle A1 - Tabares, Lucia T1 - Nifedipine ameliorates cellular differentiation defects of Smn-deficient motor neurons and enhances neuromuscular transmission in SMA mice JF - International Journal of Molecular Sciences N2 - In spinal muscular atrophy (SMA), mutations in or loss of the Survival Motor Neuron 1 (SMN1) gene reduce full-length SMN protein levels, which leads to the degeneration of a percentage of motor neurons. In mouse models of SMA, the development and maintenance of spinal motor neurons and the neuromuscular junction (NMJ) function are altered. Since nifedipine is known to be neuroprotective and increases neurotransmission in nerve terminals, we investigated its effects on cultured spinal cord motor neurons and motor nerve terminals of control and SMA mice. We found that application of nifedipine increased the frequency of spontaneous Ca\(^{2+}\) transients, growth cone size, cluster-like formations of Cav2.2 channels, and it normalized axon extension in SMA neurons in culture. At the NMJ, nifedipine significantly increased evoked and spontaneous release at low-frequency stimulation in both genotypes. High-strength stimulation revealed that nifedipine increased the size of the readily releasable pool (RRP) of vesicles in control but not SMA mice. These findings provide experimental evidence about the ability of nifedipine to prevent the appearance of developmental defects in SMA embryonic motor neurons in culture and reveal to which extent nifedipine could still increase neurotransmission at the NMJ in SMA mice under different functional demands. KW - spinal muscular atrophy KW - motor neurons KW - synaptic transmission KW - neuromuscular junction KW - calcium channels KW - nifedipine KW - growth cone KW - axons KW - synaptic vesicles KW - postsynaptic potentials Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313636 SN - 1422-0067 VL - 24 IS - 8 ER - TY - JOUR A1 - Stöckli, K. A. A1 - Lottspeich, F. A1 - Sendtner, Michael A1 - Masiakowski, P. A1 - Carroll, Patrick A1 - Götz, Rudolf A1 - Lindholm, D. A1 - Thoenen, Hans T1 - Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor N2 - CILIARY neurotrophic factor (CNTF) was originally characterized as a survival factor for chick ciliary neurons in vitro. More recently, it was shown to promote the survival of a variety of otherneuronal cell types and to affect the differentiation of E7 chick sympathetic neurons by inhibiting their proliferation and by inducing the expression of yasoactiYe intestinal peptide immunoreactiyity (VIP-IR). In cultures of dissociated sympathetic neurons from newborn rats, CNTF induces cholinergic differentiation as shown by increased levels of choline acetyltransferase (ChAT. Y1 - 1989 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-34229 ER - TY - JOUR A1 - Stöckli, K. A. A1 - Lililien, L. E. A1 - Näher- Noé, M. A1 - Breitfeld, G. A1 - Hughes, Richard A. A1 - Raff, M. C. A1 - Thoenen, Hans A1 - Sendtner, Michael T1 - Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain N2 - Ciliary neurotrophic factor (CNTF) is a potent survival molecule for a variety of embryonic neurons in culture. The developmental expression of CNTF occurs clearly after the time period of the physiological cell death of CNTF-responsive neurons. This, together with the sites of expression, excludes CNTF as a target-derived neuronal survival factor, at least in rodents. However, CNTF also participates in the induction of type 2 astrocyte differentiation in vitro. Here we demonstrate that the time course of the expression of CNTF-mRNA and protein in the rat optic nerve (as evaluated by quantitative Northern blot analysis and biological activity, respectively) is compatible with such a glial differentiation function of CNTF in vivo. We also show that the type 2 astrocyte-inducing- activity previously demonstrated in optic nerve extract can be precipitated by an antiserum against CNTF. Immunohistochemical analysis of astrocytes in vitro and in vivo demonstrates that the expression of CNTF is confined to a subpopulation of type 1 astrocytes. The olfactory bulb of adult rats has comparably high levels of CNTF to the optic nerve, and here again, CNTF-immunoreactivity is localized in a subpopulation of astrocytes. However, the postnatal expression of CNTF in the olfactory bulb occurs later than in the optic nerve. In other brain regions both CNTF-mRNA and protein levels are much lower. Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31172 ER - TY - JOUR A1 - Stengel, Helena A1 - Vural, Atay A1 - Brunder, Anna-Michelle A1 - Heinius, Annika A1 - Appeltshauser, Luise A1 - Fiebig, Bianca A1 - Giese, Florian A1 - Dresel, Christian A1 - Papagianni, Aikaterini A1 - Birklein, Frank A1 - Weis, Joachim A1 - Huchtemann, Tessa A1 - Schmidt, Christian A1 - Körtvelyessy, Peter A1 - Villmann, Carmen A1 - Meinl, Edgar A1 - Sommer, Claudia A1 - Leypoldt, Frank A1 - Doppler, Kathrin T1 - Anti–pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy JF - Neurology: Neuroimmunology & Neuroinflammation N2 - Objective To identify and characterize patients with autoantibodies against different neurofascin (NF) isoforms. Methods Screening of a large cohort of patient sera for anti-NF autoantibodies by ELISA and further characterization by cell-based assays, epitope mapping, and complement binding assays. Results Two different clinical phenotypes became apparent in this study: The well-known clinical picture of subacute-onset severe sensorimotor neuropathy with tremor that is known to be associated with IgG4 autoantibodies against the paranodal isoform NF-155 was found in 2 patients. The second phenotype with a dramatic course of disease with tetraplegia and almost locked-in syndrome was associated with IgG3 autoantibodies against nodal and paranodal isoforms of NF in 3 patients. The epitope against which these autoantibodies were directed in this second phenotype was the common Ig domain found in all 3 NF isoforms. In contrast, anti–NF-155 IgG4 were directed against the NF-155–specific Fn3Fn4 domain. The description of a second phenotype of anti–NF-associated neuropathy is in line with some case reports of similar patients that were published in the last year. Conclusions Our results indicate that anti–pan-NF-associated neuropathy differs from anti–NF-155-associated neuropathy, and epitope and subclass play a major role in the pathogenesis and severity of anti–NF-associated neuropathy and should be determined to correctly classify patients, also in respect to possible differences in therapeutic response. KW - neurology Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-202462 VL - 6 IS - 5 ER - TY - THES A1 - Simon, Christian Marc T1 - Effects of the neurotrophic factors CNTF and IGF-1 in mouse models for spinal muscular atrophy and diabetic neuropathy T1 - Effekte der neurotrophen Faktoren CNTF und IGF-1 in Mausmodellen für spinale Muskelatrophie und diabetische Neuropathie N2 - In this study I investigate the role of Schwann cell and axon-derived trophic signals as modifiers of axonal integrity and sprouting in motoneuron disease and diabetic neuropathy (DNP). The first part of this thesis focuses on the role of the Schwann-cell-derived ciliary neurotrophic factor (CNTF) for compensatory sprouting in a mouse model for mild spinal muscular atrophy (SMA). In the second part, the role of the insulin-like growth factor 1 (IGF-1) and its binding protein 5 (IGFBP-5) is examined in the peripheral nerves of patients with DNP and in two corresponding mouse models. Proximal SMA is caused by homozygous loss or mutation of the SMN1 gene on human chromosome 5. The different forms of SMA can be divided into four groups, depending on the levels of SMN protein produced from a second SMN gene (SMN2) and the severity of the disease. Patients with milder forms of the disease, type III and type IV SMA, normally reach adulthood and regularly show enlargement of motor units, signifying the reinnervation of denervated muscle fibers. However, the underlying mechanisms are not understood. Smn+/- mice, a model of type III/IV SMA, are phenotypically normal, but they reveal progressive loss of motor neurons and denervation of motor endplates starting at 4 weeks of age. The progressive loss of spinal motor neurons reaches 50% at 12 months but muscle strength is not reduced. The first evidence for axonal sprouting as a compensatory mechanism in these animals was the more than 2-fold increase in amplitude of single motor unit action potentials (SMUAP) in the gastrocnemius muscle. Confocal analysis confirmed pronounced sprouting of innervating motor axons. As CNTF is highly expressed in Schwann cells and known to be involved in sprouting, its role for this compensatory sprouting response and the maintenance of muscle strength in Smn+/- mice was investigated. Deletion of CNTF in this mouse model results in reduced sprouting and decline of muscle strength in Smn+/- Cntf-/- mice. These findings indicate that CNTF is necessary for a sprouting response and thus enhances the size of motor units in skeletal muscles of Smn+/- mice. DNP afflicting motor and sensory nerve fibers is a major complication in diabetes mellitus. The underlying cellular mechanisms of motor axon degeneration are poorly understood. IGFBP-5, an inhibitory binding protein for IGF-1, is highly upregulated in peripheral nerves in patients with DNP. The study investigates the pathogenic relevance of this finding in transgenic mice overexpressing IGFBP-5 in motor axons. These mice develop motor axonopathy similar to that seen in DNP. Motor axon degeneration is also observed in mice in which the IGF-1 receptor (IGF-1R) was conditionally depleted in motoneurons, indicating that reduced activity of IGF-1 on IGF-1R in motoneurons is responsible for the observed effect. These data provide evidence that elevated expression of IGFBP-5 in diabetic nerves reduces the availability of IGF-1 for IGF-1R on motor axons leading to progressive neurodegeneration, and thus offers novel treatment strategies. N2 - In dieser Arbeit habe ich die Rolle der neurotrophen Faktoren Ciliary neurotrophic factor (CNTF) und Insulin-like-growth factor 1 (IGF-1), die in Schwannzellen gebildet werden, als Modulatoren der axonalen Integrität bei einer degenerativen Motoneuronenerkrankung und bei diabetischer Neuropathie (DNP) untersucht. Im ersten Teil dieser Arbeit wird gezeigt, dass CNTF für ein kompensatorisches Sprouting von motorischen Axonen in einem Mausmodell für spinale Muskelatrophie (SMA) verantwortlich ist. Im zweiten Teil wird die Rolle von IGF-1 und dessen Bindeprotein, IGFBP-5, in Axonen motorischer Nerven bei Patienten mit DNP und zwei korrespondieren Mausmodellen gezeigt. Die proximale SMA wird durch einen homozygoten Verlust oder Mutation des SMN1 Gens auf dem Chromosom 5 verursacht. Bei der spinalen Muskelatrophie unterscheidet man verschiedene Schweregrade, abhängig von der Menge an SMN Protein, das vom zweiten SMN Gen (SMN2) produziert werden kann. Patienten mit einer milderen Form von SMA (Typ III und IV) erreichen das Erwachsenenalter und zeigen oft vergrößerte motorische Einheiten, im Gegensatz zu Patienten mit den schweren kindlichen Formen der Erkrankung. Smn+/- Mäuse, ein Modell für die leichten SMA Formen Typ II und IV, zeigen denervierte Endplatten bereits 4 Wochen nach der Geburt und einen fortschreitenden Verlust von Motoneuronen, der nach 12 Monaten mehr als 50% beträgt, ohne dass sich die Muskelkraft der Tiere verringert. Die Amplitude der Summenpotenziale von einzelnen motorischen Einheiten (Single motor unit action potential, SMUAP) im Wadenmuskel ist mehr als 2-fach erhöht. Konfokale Aufnahmen bestätigen ausgeprägtes Sprouting der noch innervierenden Axone. Smn+/- Mäuse ohne CNTF, das normalerweise stark in Schwann-Zellen exprimiert ist, zeigen reduziertes Sprouting und verringerte Muskelkraft. Diese Ergebnisse sprechen dafür, dass CNTF für das Sprouting und die vergrößerten motorischen Einheiten in Smn+/- Mäusen verantwortlich ist. Dieser kompensatorische Mechanismus könnte neue Behandlungs-möglichkeiten für Motoneuronerkrankungen eröffnen. Die Diabetische Neuropathie (DNP), eine der Hauptkomplikationen bei Diabetes Mellitus, betrifft sowohl motorische als auch sensorische Nervenfasern. Die zugrunde liegenden zellulären Mechanismen, die zur Degeneration motorischer Axone in Spätstadien der Erkrankung führen, sind größtenteils noch ungeklärt. IGFBP-5, ein IGF-1 hemmendes Bindeprotein, ist in peripheren Nervbiopsien von DNP Patienten stark überexprimiert. Diese potenzielle pathogene Relevanz wurde bei IGFBP-5 überexprimierenden transgenen Mäusen untersucht. Diese Mäuse entwickeln ähnlich wie die DNP Patienten eine motorische Axonopathie. Diese Axondegeneration zeigen auch Mäuse, bei denen der IGF-1 Rezeptor (IGF-1R) neuronenspezifisch ausgeschaltet wurde. Das bedeutet, dass reduzierte Wirkung von IGF-1 am IGF-1R auf Axonen von Motoneuronen für die beobachtete Axonopathie verantwortlich ist. Zusammenfassend zeigen diese Daten, dass erhöhtes IGFBP-5 in diabetischen Nerven die Verfügbarkeit von IGF-1 für den IGF-1R reduziert und zu progressiver Neurodegeneration führt. Diese Erkenntnis könnte neue Behandlungsstrategien für Patienten mit DNP eröffnen. KW - Spinale Muskelatrophie KW - Ciliary neurotrophic factor KW - Insulin-like-Growth-Factor-Binding-Protein-5 KW - Diabetische Polyneuropathie KW - Insulin-like Growth KW - Spinal muscular atrophy KW - Ciliary neurotrophic factor KW - Insulin-like-Growth-Factor-Binding-Protein-5 KW - Diabetic polyneuropathy Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-70207 ER - TY - JOUR A1 - Sendtner, Michael A1 - Thoenen, Hans A1 - Hughes, R. A. T1 - Members of several gene families influence survival of rat motoneurons in vitro and in vivo N2 - The survival and functional maintenance of spinal motoneurons, both during the period of developmental cell death and in adulthood, have been shown to be dependent on trophic factors. In vitro experiments have previously been used to identify several survival factors for motoneurons, including CNTF, UF, and members of the neurotrophin, FGF, and IGF gene families. Some of these factors have also been shown to be active in vivo, either on chick motoneurons during embryonic development or on lesioned facial and spinal motoneurons of the newborn rat. Here we demonstrate that lesioned newborn rat facial motoneurons can be rescued by NT-4/5, IGF-I, and UF. Furthermore, in contrast to chick motoneurons, the survival of isolated embryonic rat motoneurons can be maintained by the neurotrophins BDNF, NT-3, and NT-4/5. IGF-I and FGF-5 were also active in this system, each supporting more than 50% of the originally plated neurons. The responsiveness of motoneurons to multiple factors in vitro and in vivo suggests that motoneuron survival and function are regulated by the coordinated actions of members of different gene families. KW - Immunopanning KW - Facial Nerve Transection KW - Neurotrophin KW - Fibroblast Growth Factor KW - Insulinlike Growth Factor Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42652 ER - TY - JOUR A1 - Sendtner, Michael A1 - Thoenen, Hans A1 - Holtmann, B. A1 - Kohlbeck, R. A1 - Barde, Y.-A. T1 - Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section N2 - Motoneurons innervating the skeletal musculature were among the first neurons shown to require the presence of their target cells to develop appropriatelyl,2. But the characterization of molecules allowing motoneuron survival has been difficult. Ciliary neurotrophic factor prevents the death of motoneurons3-6, but its gene is not expressed during development7. Although the presence of a neurotrophin receptor on developing motoneurons8-1O has suggested a role for neurotrophins, none could be shown to promote motoneuron survival in vitro3. We report here that brainderived neurotrophic factor can prevent the death of axotomized motoneurons in newborn rats, suggesting a role for this neurotrophin for motoneuron survival in vivo. Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42673 ER -